Iguratimod TCI I0945

Iguratimod TCI I0945 123663-49-0 is a chemical compound widely used in pharmaceutical research for exploring the mechanisms of drug action. As a research reagent, it plays a crucial role in experimental settings where the investigation of immunological activities and inflammatory responses is required. This compound is essential for scientists aiming to understand how drugs interact with biological systems, particularly in the context of immunomodulation. Its inclusion in the category of pharmaceutical research reagents highlights its importance in both academic and industrial research environments.

The stability of Iguratimod’s chemical properties makes it a preferred choice for laboratories that require precise dosing and consistent results. Its ability to maintain chemical integrity under normal conditions simplifies storage and handling, ensuring reliability in experimental outcomes. High purity and consistent quality further enhance its suitability for applications where accuracy is paramount. These characteristics make it an ideal reagent for experiments demanding reproducibility and precision, supporting a wide range of research objectives.

In Indonesian laboratories, Iguratimod is commonly used in pharmacological and immunological studies to test the effects of drugs on the immune system. It serves as a key tool in the development of new pharmaceuticals and in studying the mechanisms of various diseases. Due to its reliability and performance, it is frequently selected by researchers for its ability to provide consistent and accurate data in experimental settings.

• Pharmaceutical research for studying drug mechanisms and immunological responses due to its stable chemical properties and precise dosing capabilities.
• Immunological studies to evaluate the effects of compounds on immune system functions and inflammatory processes.
• Development of new drugs where accurate and reproducible experimental results are essential for drug discovery and formulation.
• In vitro and in vivo experiments requiring reliable reagents that maintain consistency across multiple trials.
• Disease mechanism studies to understand how various conditions affect biological pathways and response to therapeutic agents.

Iguratimod should be stored in a cool, dry environment to maintain its chemical stability and prevent degradation. It is recommended to keep the reagent in a sealed container to avoid exposure to moisture and air, which could affect its integrity. Laboratory personnel should handle the compound with appropriate personal protective equipment, such as gloves and safety goggles, to ensure safety during use. The reagent should be stored away from incompatible substances to prevent chemical interactions. Regular monitoring of storage conditions is advised to ensure the reagent remains in optimal condition for experimental use. Proper labeling of containers is essential to prevent mix-ups and ensure safe handling in a laboratory setting.

—